Illumina sequencing and array products facilitate clinical cancer research by providing expert-defined gene content, accurate data, and simple analysis and reporting options.
Featured Sequencing Research Panels
AmpliSeq for Illumina Sequencing Panels—Optimized for clinical cancer research applications and available
as predesigned or made-to-order panels; use with targets ranging
from a few to hundreds of genes in a single run.
TruSight RNA Fusion—This targeted RNA sequencing research panel is a cost-effective
solution to detect gene fusions in multiple cancer types, regardless
TruSight Tumor 170—Comprehensive research panel detects single-nucleotide variants
(SNVs), amplifications, and fusions that contribute to solid tumor
TruSight Oncology UMI Reagents—The TruSight Oncology UMI Reagents and UMI Error Correction App
reduce error rates in samples to ≤0.007%, enabling the detection of
low frequency variants.
TruSight RNA Pan-Cancer—Targeting 1385 oncology genes for gene expression, variant and
fusion detection studies in all RNA sample types including FFPE.
TruSight Tumor 15—Focused research panel to assess relevant solid tumor somatic
variants in a simple, sample-to-data workflow.
Infinium OncoArray-500K BeadChip—An expert-designed, high-density array for researching cancer predisposition and risk. Contains ~500,000 genome-wide SNPs, plus putative SNPs associated with breast, colorectal, lung, ovarian, and prostate cancer.